author-photo

N. E. Tchabo

Morristown Medical Center

3

Papers

18

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

2016 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (16)
Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

2013 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
A randomized, open-label phase IIb study of maintenence therapy with a MUC-1 dendritic cell vaccine in patients with epithelial ovarian cancer in first or second remission.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)